1. Home
  2. BFLY vs NEO Comparison

BFLY vs NEO Comparison

Compare BFLY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

HOLD

Current Price

$4.44

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFLY
NEO
Founded
2011
2001
Country
United States
United States
Employees
220
N/A
Industry
Medical Electronics
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BFLY
NEO
Price
$4.44
$9.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$5.00
$13.38
AVG Volume (30 Days)
5.1M
2.0M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.01
$10.63
Revenue Next Year
$19.93
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$4.72
52 Week High
$5.72
$13.74

Technical Indicators

Market Signals
Indicator
BFLY
NEO
Relative Strength Index (RSI) 50.27 60.46
Support Level $3.63 $7.42
Resistance Level $5.00 $10.82
Average True Range (ATR) 0.28 0.40
MACD -0.01 0.04
Stochastic Oscillator 53.57 89.45

Price Performance

Historical Comparison
BFLY
NEO

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: